Fred Hutchinson Cancer Center
Facts
- HQ
- Federal Way
- Sectors
- Healthcare, Medical research, Cancer research
- Founded
- 1976
Seattle Startup Nexgenia Raises $2M to Broaden Polymer Reagent Technology for Immunotherapy Applications
Seattle biotech startup Nexgenia, led by CEO Ron Myers, raised $2 million to expand its polymer-based reagents for sorting cells in immunotherapy production to new applications. The funding, led by the W Fund and Washington Research Foundation, will support further research into diverse uses of their technology beyond cancer treatment.
People
-
Jeff Leek Executive, Co-founder and Chief Data Officer